DGAP-News: MediClin AG: Group sales increased to EUR 509.7 mill., preliminary Group operating result

DGAP-News: MediClin AG: Group sales increased to EUR 509.7 mill., preliminary Group operating result amounts to EUR 4.3 mill.

ID: 234916

(firmenpresse) - DGAP-News: MediClin AG / Key word(s): Preliminary Results
MediClin AG: Group sales increased to EUR 509.7 mill., preliminary
Group operating result amounts to EUR 4.3 mill.

01.03.2013 / 14:00

---------------------------------------------------------------------

MediClin AG: Group sales increased to EUR 509.7 mill., preliminary Group
operating result amounts to EUR 4.3 mill.

Offenburg, March 1, 2013 - In the 2012 financial year MEDICLIN
Aktiengesellschaft (MediClin) achieved Group sales in the amount of EUR
509.7 mill. (2011: 493.6 Mio. Euro) which is EUR 16.1 mill. above previous
year's value. The preliminary Group operating result amounts to EUR 4.3
mill. (2011: EUR 12.6 mill.). The Group operating result is burdened in
2012 by higher other operating expenses, special items and one-time effects
towards the end of the year in the range of EUR 2.8 million and higher
staff costs. The preliminary result attributable to shareholders of
MediClin AG accounts for EUR -1.4 mill. (2011: EUR 3.1 mill.).

In 2012 nearly 2.6 million nursing days were provided and more than 121
thousand cases were treated. In the Group the occupancy was 86.3% clearly
above the previous year's figure (2011: 84.8%).

The number of staff, calculated on the basis of full-time staff, increased
on an annual average by 157 employees and was on average in 2012 at 6,256
full-time employees (2011: 6,099 full-time employees).

EUR 27.3 mill. (gross capital expenditure) were invested in 2012 (2011:
EUR 29.9 mill.). The cashflow from operating activities amounts to EUR 16.2
mill. (2011: EUR 15.6 mill.).

On the cost side raw materials and consumables used increased only slightly
up to EUR 111.2 mill. The cost of materials ratio decreased to 21.8% (2011:
22.4%) due to increased sales. Staff costs increased by EUR 13.4 mill. up
to EUR 290.4 mill. The staff costs ratio is 57.0% (2011: 56.1%). Other




operating expenses amounted to EUR 94.5 mill. (2011: EUR 89.3 mill.) and
were above last years value due to higher rental and leasing expenses,
higher repair and maintenance and higher legal and advisory costs.

Despite higher occupancy in both segments post-acute and acute the segment
results were below last year

EUR 13.7 mill. out of EUR 16.1 mill. sales increase applied to the
post-acute segment. Sales of the acute segment decreased slightly by EUR
0.7 mill. The result of the post-acute segment lies at EUR 2.6 mill. (2011:
EUR 2.8 mill.) due to a strong decrease in occupancy at the end of the
year. The acute segment result decreased to EUR 7.2 mill. from EUR 15,5
mill. because additional services were not or not totally compensated and
especially staff costs increased compared to last year. The development of
the business field nursing care was very satisfying, sales increased by EUR
1.1 mill. to EUR13.1 mill. The occupancy was at 96.2% (2011: 94.7%).

The balance sheet and analyst conference will take place on March 22, 2013
in Frankfurt. From that day onwards also our annual report 2012 will be
available at www.mediclin.de



About MediClin AG (Ticker: MED; WKN: 659 510)

MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungs-zentren (medical care units) in 11 federal states MediClin has
a total capacity of approximately 8,100 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,500 employees.


End of Corporate News

---------------------------------------------------------------------

01.03.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr(at)mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart


End of News DGAP News-Service
---------------------------------------------------------------------
202798 01.03.2013


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Santee Water Damage Co Wins 5th Award in Customer Satisfaction Talk of the Town DGAP-News: Brazil Resources Inc. Appoints Former Minister of Natural Resources, the Honourable Herb Dhaliwal, to Its Board of Directors and Grants Stock Options
Bereitgestellt von Benutzer: EquityStory
Datum: 01.03.2013 - 14:00 Uhr
Sprache: Deutsch
News-ID 234916
Anzahl Zeichen: 4940

contact information:

Kategorie:

Business News



Diese Pressemitteilung wurde bisher 252 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"DGAP-News: MediClin AG: Group sales increased to EUR 509.7 mill., preliminary Group operating result amounts to EUR 4.3 mill."
steht unter der journalistisch-redaktionellen Verantwortung von

MediClin AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von MediClin AG



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z